In the BioHarmony Drug Report Database
Cephalexin
Keflet, Keflex (cephalexin) is a small molecule pharmaceutical. Cephalexin was first approved as Keflet on 1982-01-01. It is used to treat bacterial infections, bacterial pneumonia, bacterial skin diseases, escherichia coli infections, and haemophilus infections amongst others in the USA.
Trade Name
|
Keflet, Keflex |
|---|---|
Common Name
|
cephalexin |
ChEMBL ID
|
CHEMBL1200544 |
Indication
|
bacterial infections, bacterial pneumonia, bacterial skin diseases, escherichia coli infections, haemophilus infections, human bites, infectious bone diseases, klebsiella infections, moraxellaceae infections, otitis media, pharyngitis, proteus infections, soft tissue infections, staphylococcal infections, streptococcal infections, surgical wound infection, urinary tract infections |
Drug Class
|
First-generation cephalosporin |
Image (chem structure or protein)